| Application Number | Priority Date | Filing Date | Title | 
|---|---|---|---|
| US87694706P | 2006-12-22 | 2006-12-22 | |
| PCT/NZ2007/000387WO2008079028A1 (en) | 2006-12-22 | 2007-12-21 | Azetidine analogues of nucleosidase and phosphorylase inhibitors | 
| Publication Number | Publication Date | 
|---|---|
| ATE553105T1true ATE553105T1 (de) | 2012-04-15 | 
| Application Number | Title | Priority Date | Filing Date | 
|---|---|---|---|
| AT07866894TATE553105T1 (de) | 2006-12-22 | 2007-12-21 | Azetidin-analoge ais nucleosidase- und phosphorylase-hemmer | 
| Country | Link | 
|---|---|
| US (1) | US8283345B2 (de) | 
| EP (1) | EP2114925B8 (de) | 
| JP (1) | JP2010513477A (de) | 
| KR (1) | KR20090101278A (de) | 
| CN (1) | CN101600711A (de) | 
| AT (1) | ATE553105T1 (de) | 
| AU (1) | AU2007338953A1 (de) | 
| CA (1) | CA2674525A1 (de) | 
| CY (1) | CY1112889T1 (de) | 
| DK (1) | DK2114925T3 (de) | 
| ES (1) | ES2385759T3 (de) | 
| NZ (1) | NZ577682A (de) | 
| PT (1) | PT2114925E (de) | 
| WO (1) | WO2008079028A1 (de) | 
| Publication number | Priority date | Publication date | Assignee | Title | 
|---|---|---|---|---|
| PT1539783E (pt)* | 2002-08-21 | 2011-06-01 | Einstein Coll Med | Inibidores de nucleósido fosforilases e de nucleosidases | 
| NZ523970A (en)* | 2003-02-04 | 2005-02-25 | Ind Res Ltd | Process for preparing inhibitors of nucleoside phoshorylases and nucleosidases | 
| NZ533360A (en) | 2004-06-04 | 2007-02-23 | Ind Res Ltd | Improved method for preparing 3-hydroxy-4-hydroxymethyl-pyrrolidine compounds | 
| US9512125B2 (en) | 2004-11-19 | 2016-12-06 | The Regents Of The University Of California | Substituted pyrazolo[3.4-D] pyrimidines as anti-inflammatory agents | 
| US8541567B2 (en) | 2005-07-27 | 2013-09-24 | Albert Einstein College Of Medicine Of Yeshiva University | Transition state structure of 5′-methylthioadenosine/s-adenosylhomocysteine nucleosidases | 
| NZ544187A (en)* | 2005-12-15 | 2008-07-31 | Ind Res Ltd | Deazapurine analogs of 1'-aza-l-nucleosides | 
| WO2007097643A1 (en) | 2006-02-22 | 2007-08-30 | Industrial Research Limited | Analogues of coformycin and their use for treating protozoan parasite infections | 
| AU2007218334A1 (en)* | 2006-02-24 | 2007-08-30 | Albert Einstein College Of Medicine Of Yeshiva University | Methods of treating diseases using inhibitors of nucleoside phosphorylases and nucleosidases | 
| US8916571B2 (en) | 2006-02-24 | 2014-12-23 | Albert Einstein College Of Medicine Of Yeshiva University | Methods of treating cancer using inhibitors of 5′-methylthioadenosine phosphorylase | 
| ES2423010T3 (es) | 2006-04-04 | 2013-09-17 | The Regents Of The University Of California | Derivados de pirazolopirimidina para su uso como antagonistas de cinasa | 
| AU2007293773B2 (en)* | 2006-09-07 | 2013-01-31 | Albert Einstein College Of Medicine, Inc. | Acyclic amine inhibitors of 5'-methylthioadenosine phosphorylase and nucleosidase | 
| KR101433621B1 (ko) | 2006-09-07 | 2014-08-27 | 알버트 아인슈타인 컬리지 오브 메디신 오브 예쉬바 유니버시티 | 누클레오시드 포스포릴라아제 및 히드롤라아제의 비고리형 아민 억제제 | 
| GB2467670B (en) | 2007-10-04 | 2012-08-01 | Intellikine Inc | Chemical entities and therapeutic uses thereof | 
| US8193182B2 (en) | 2008-01-04 | 2012-06-05 | Intellikine, Inc. | Substituted isoquinolin-1(2H)-ones, and methods of use thereof | 
| KR101660050B1 (ko) | 2008-01-04 | 2016-09-26 | 인텔리카인, 엘엘씨 | 특정 화학 물질, 조성물 및 방법 | 
| US8993580B2 (en) | 2008-03-14 | 2015-03-31 | Intellikine Llc | Benzothiazole kinase inhibitors and methods of use | 
| JP5547099B2 (ja) | 2008-03-14 | 2014-07-09 | インテリカイン, エルエルシー | キナーゼ阻害剤および使用方法 | 
| US20110224223A1 (en) | 2008-07-08 | 2011-09-15 | The Regents Of The University Of California, A California Corporation | MTOR Modulators and Uses Thereof | 
| NZ590258A (en) | 2008-07-08 | 2013-10-25 | Intellikine Llc | Kinase inhibitors and methods of use | 
| EP2348854A4 (de) | 2008-09-22 | 2012-03-14 | Einstein Coll Med | Verfahren und zusammensetzungen für die behandlung von bakteriellen infektionen durch hemmung des »quorum sensing | 
| CA2738429C (en) | 2008-09-26 | 2016-10-25 | Intellikine, Inc. | Heterocyclic kinase inhibitors | 
| EP2358720B1 (de) | 2008-10-16 | 2016-03-02 | The Regents of The University of California | Heteroarylkinasehemmer mit kondensierten ringen | 
| US8476431B2 (en) | 2008-11-03 | 2013-07-02 | Itellikine LLC | Benzoxazole kinase inhibitors and methods of use | 
| GB0904287D0 (en) | 2009-03-12 | 2009-04-22 | Prosidion Ltd | Compounds for the treatment of metabolic disorders | 
| CA2760791C (en) | 2009-05-07 | 2017-06-20 | Intellikine, Inc. | Heterocyclic compounds and uses thereof | 
| US9493465B2 (en) | 2009-07-17 | 2016-11-15 | Victoria Link Limited | 3-hydroxypyrrolidine inhibitors of 5′-methylthioadenosine phosphorylase and nucleosidase | 
| WO2011047384A2 (en) | 2009-10-16 | 2011-04-21 | The Regents Of The University Of California | Methods of inhibiting ire1 | 
| ES2593256T3 (es) | 2010-05-21 | 2016-12-07 | Infinity Pharmaceuticals, Inc. | Compuestos químicos, composiciones y métodos para las modulaciones de cinasas | 
| AU2011326427B2 (en) | 2010-11-10 | 2016-01-07 | Infinity Pharmaceuticals Inc. | Heterocyclic compounds and uses thereof | 
| WO2012074912A1 (en) | 2010-11-29 | 2012-06-07 | Albert Einstein College Of Medicine Of Yeshiva University | Methods, assays and compounds for treating bacterial infections by inhibiting methylthioinosine phosphorylase | 
| NZ612909A (en) | 2011-01-10 | 2015-09-25 | Infinity Pharmaceuticals Inc | Processes for preparing isoquinolinones and solid forms of isoquinolinones | 
| CN103491962B (zh) | 2011-02-23 | 2016-10-12 | 因特利凯有限责任公司 | 激酶抑制剂的组合及其用途 | 
| WO2012150866A1 (en)* | 2011-05-03 | 2012-11-08 | Industrial Research Limited | Phosphoribosyltransferase inhibitors and uses thereof | 
| CA2842190A1 (en) | 2011-07-19 | 2013-01-24 | Infinity Pharmaceuticals Inc. | Heterocyclic compounds and uses thereof | 
| EP2734520B1 (de) | 2011-07-19 | 2016-09-14 | Infinity Pharmaceuticals, Inc. | Heterocyclische verbindungen und ihre verwendung | 
| MX2014002542A (es) | 2011-08-29 | 2014-07-09 | Infinity Pharmaceuticals Inc | Compuestos heterociclicos y usos de los mismos. | 
| CA2846496C (en) | 2011-09-02 | 2020-07-14 | The Regents Of The University Of California | Substituted pyrazolo[3,4-d]pyrimidines and uses thereof | 
| US8940742B2 (en) | 2012-04-10 | 2015-01-27 | Infinity Pharmaceuticals, Inc. | Heterocyclic compounds and uses thereof | 
| US8828998B2 (en) | 2012-06-25 | 2014-09-09 | Infinity Pharmaceuticals, Inc. | Treatment of lupus, fibrotic conditions, and inflammatory myopathies and other disorders using PI3 kinase inhibitors | 
| JP6063571B2 (ja) | 2012-08-07 | 2017-01-18 | アルバート アインシュタイン カレッジ オブ メディシン,インコーポレイティド | ヘリコバクター・ピロリ感染の治療 | 
| RU2015115631A (ru) | 2012-09-26 | 2016-11-20 | Дзе Риджентс Оф Дзе Юниверсити Оф Калифорния | Модулирование ire1 | 
| PL2914296T5 (pl) | 2012-11-01 | 2022-01-17 | Infinity Pharmaceuticals, Inc. | Leczenie nowotworu z zastosowaniem modulatorów izoform kinazy PI3 | 
| US9481667B2 (en) | 2013-03-15 | 2016-11-01 | Infinity Pharmaceuticals, Inc. | Salts and solid forms of isoquinolinones and composition comprising and methods of using the same | 
| US9452217B2 (en) | 2013-06-22 | 2016-09-27 | Nitor Therapeutics | Methods for potentiating immune response for the treatment of infectious diseases and cancer | 
| WO2015051241A1 (en) | 2013-10-04 | 2015-04-09 | Infinity Pharmaceuticals, Inc. | Heterocyclic compounds and uses thereof | 
| PH12016500582B1 (en) | 2013-10-04 | 2023-06-30 | Infinity Pharmaceuticals Inc | Heterocyclic compounds and uses thereof | 
| KR20160101162A (ko) | 2013-12-24 | 2016-08-24 | 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 | 코르티스타틴 유사체 및 그의 합성 및 용도 | 
| SG11201606595RA (en) | 2014-02-12 | 2016-09-29 | Einstein Coll Med | Treatment of h. pylori infections using mtan inhibitors | 
| CN113616656B (zh) | 2014-03-19 | 2023-02-17 | 无限药品股份有限公司 | 用于治疗PI3K-γ介导的障碍的杂环化合物 | 
| WO2015160975A2 (en) | 2014-04-16 | 2015-10-22 | Infinity Pharmaceuticals, Inc. | Combination therapies | 
| WO2016054491A1 (en) | 2014-10-03 | 2016-04-07 | Infinity Pharmaceuticals, Inc. | Heterocyclic compounds and uses thereof | 
| WO2016182932A1 (en) | 2015-05-08 | 2016-11-17 | President And Fellows Of Harvard College | Cortistatin analogues, syntheses, and uses thereof | 
| WO2017004411A1 (en) | 2015-07-01 | 2017-01-05 | President And Fellows Of Harvard College | Cortistatin analogues and syntheses and uses thereof | 
| JP6980649B2 (ja) | 2015-09-14 | 2021-12-15 | インフィニティー ファーマシューティカルズ, インコーポレイテッド | イソキノリノン誘導体の固体形態、それを製造する方法、それを含む組成物、及びそれを使用する方法 | 
| RU2018133138A (ru)* | 2016-02-19 | 2020-03-19 | Президент Энд Феллоус Оф Гарвард Колледж | Аналоги кортистатина | 
| WO2017161116A1 (en) | 2016-03-17 | 2017-09-21 | Infinity Pharmaceuticals, Inc. | Isotopologues of isoquinolinone and quinazolinone compounds and uses thereof as pi3k kinase inhibitors | 
| WO2017214269A1 (en) | 2016-06-08 | 2017-12-14 | Infinity Pharmaceuticals, Inc. | Heterocyclic compounds and uses thereof | 
| IL263680B1 (en) | 2016-06-24 | 2025-06-01 | Infinity Pharmaceuticals Inc | Pi3k inhibitors for use in combination with a second therapeutic agent in treating, managing, or preventing cancer | 
| MX390277B (es) | 2016-08-31 | 2025-03-20 | Servier Lab | Inhibidores de procesos metabolicos celulares. | 
| CN108069889B (zh)* | 2016-11-10 | 2021-10-01 | 上海西浦医药科技有限公司 | 一种氮杂环丁烷-3-甲酸的合成方法 | 
| JP2023508978A (ja)* | 2019-12-23 | 2023-03-06 | サンフォード バーナム プレビス メディカル ディスカバリー インスティテュート | エクトヌクレオチドピロホスファターゼ/ホスホジエステラーゼ1(enpp1)モジュレーター及びその使用 | 
| GB202218782D0 (en) | 2022-12-13 | 2023-01-25 | Mehrling Thomas | Purine nucleoside phosphorylase inhibitor for metabolic syndrome | 
| CN116478172B (zh)* | 2023-06-20 | 2023-09-05 | 英矽智能科技(上海)有限公司 | 吡咯并[3,2-d]嘧啶类化合物及其应用 | 
| Publication number | Priority date | Publication date | Assignee | Title | 
|---|---|---|---|---|
| WO1997031008A1 (en)* | 1996-02-23 | 1997-08-28 | Industrial Research Limited | Enzyme detection/assay method and substrates | 
| GB9609374D0 (en)* | 1996-05-03 | 1996-07-10 | Merck Sharp & Dohme | Therapeutic agents | 
| US5985848A (en)* | 1997-10-14 | 1999-11-16 | Albert Einstein College Of Medicine Of Yeshiva University | Inhibitors of nucleoside metabolism | 
| TR200002466T2 (tr)* | 1998-02-26 | 2000-12-21 | Akzo Nobel N.V. | Azetidin ve pirolidin türevleri | 
| CA2368095C (en)* | 1999-04-08 | 2009-10-06 | Industrial Research Limited | Process for preparing inhibitors of nucleoside metabolism | 
| US6448799B1 (en)* | 1999-09-30 | 2002-09-10 | Hitachi Electronics Engineering Co., Ltd. | Timing adjustment method and apparatus for semiconductor IC tester | 
| US7109331B2 (en)* | 2000-08-29 | 2006-09-19 | Industrial Research Limited | 5H-pyrrolo[3,2-d]pyrimidine nucleoside metabolism inhibitors | 
| US6458799B1 (en) | 2000-08-31 | 2002-10-01 | Biocryst Pharmaceuticals, Inc. | Deazaguanine analog, preparation thereof and use thereof | 
| US7098334B2 (en)* | 2002-03-25 | 2006-08-29 | Industrial Research Limited | 4-amino-5H-pyrrolo[3,2-d]pyrimidine inhibitors of nucleoside phosphorylases and nucleosidases | 
| PT1539783E (pt)* | 2002-08-21 | 2011-06-01 | Einstein Coll Med | Inibidores de nucleósido fosforilases e de nucleosidases | 
| EP1569933B1 (de)* | 2002-12-13 | 2008-07-23 | SmithKline Beecham Corporation | Pyrrolidin- und azetidinverbindungen alsccr5-antagonisten | 
| NZ523970A (en)* | 2003-02-04 | 2005-02-25 | Ind Res Ltd | Process for preparing inhibitors of nucleoside phoshorylases and nucleosidases | 
| JP2007504246A (ja)* | 2003-09-05 | 2007-03-01 | イェシバ・ユニバーシティ | チミジンホスホリラーゼの遷移状態構造および阻害剤 | 
| NZ533360A (en) | 2004-06-04 | 2007-02-23 | Ind Res Ltd | Improved method for preparing 3-hydroxy-4-hydroxymethyl-pyrrolidine compounds | 
| JP2008508287A (ja) | 2004-07-27 | 2008-03-21 | バイオクリスト・フアーマシユーテイカルズ・インコーポレイテツド | 5’−メチルチオアデノシンホスホリラーゼ及び5’メチルチオアデノシン/s−アデノシルホモシステインヌクレオシダーゼの阻害剤 | 
| NZ540160A (en) | 2005-05-20 | 2008-03-28 | Einstein Coll Med | Inhibitors of nucleoside phosphorylases | 
| US8541567B2 (en) | 2005-07-27 | 2013-09-24 | Albert Einstein College Of Medicine Of Yeshiva University | Transition state structure of 5′-methylthioadenosine/s-adenosylhomocysteine nucleosidases | 
| NZ544187A (en)* | 2005-12-15 | 2008-07-31 | Ind Res Ltd | Deazapurine analogs of 1'-aza-l-nucleosides | 
| AU2007218334A1 (en) | 2006-02-24 | 2007-08-30 | Albert Einstein College Of Medicine Of Yeshiva University | Methods of treating diseases using inhibitors of nucleoside phosphorylases and nucleosidases | 
| US8916571B2 (en)* | 2006-02-24 | 2014-12-23 | Albert Einstein College Of Medicine Of Yeshiva University | Methods of treating cancer using inhibitors of 5′-methylthioadenosine phosphorylase | 
| KR101433621B1 (ko) | 2006-09-07 | 2014-08-27 | 알버트 아인슈타인 컬리지 오브 메디신 오브 예쉬바 유니버시티 | 누클레오시드 포스포릴라아제 및 히드롤라아제의 비고리형 아민 억제제 | 
| AU2007293773B2 (en) | 2006-09-07 | 2013-01-31 | Albert Einstein College Of Medicine, Inc. | Acyclic amine inhibitors of 5'-methylthioadenosine phosphorylase and nucleosidase | 
| WO2008039324A1 (en) | 2006-09-26 | 2008-04-03 | Albert Einstein College Of Medicine Of Yeshiva University | Transition state structure of human 5'-methylthioadenosine phosphorylase | 
| WO2009082247A1 (en) | 2007-12-21 | 2009-07-02 | Industrial Research Limited | Process for preparing immucillins having a methylene link | 
| EP2348854A4 (de) | 2008-09-22 | 2012-03-14 | Einstein Coll Med | Verfahren und zusammensetzungen für die behandlung von bakteriellen infektionen durch hemmung des »quorum sensing | 
| US9493465B2 (en) | 2009-07-17 | 2016-11-15 | Victoria Link Limited | 3-hydroxypyrrolidine inhibitors of 5′-methylthioadenosine phosphorylase and nucleosidase | 
| Publication number | Publication date | 
|---|---|
| EP2114925B8 (de) | 2013-04-10 | 
| US8283345B2 (en) | 2012-10-09 | 
| DK2114925T3 (da) | 2012-05-29 | 
| ES2385759T3 (es) | 2012-07-31 | 
| HK1138276A1 (en) | 2010-08-20 | 
| US20100168141A1 (en) | 2010-07-01 | 
| JP2010513477A (ja) | 2010-04-30 | 
| PT2114925E (pt) | 2012-05-29 | 
| CA2674525A1 (en) | 2008-07-03 | 
| AU2007338953A1 (en) | 2008-07-03 | 
| EP2114925A4 (de) | 2010-10-20 | 
| EP2114925A1 (de) | 2009-11-11 | 
| NZ577682A (en) | 2012-03-30 | 
| EP2114925B1 (de) | 2012-04-11 | 
| KR20090101278A (ko) | 2009-09-24 | 
| CY1112889T1 (el) | 2016-04-13 | 
| CN101600711A (zh) | 2009-12-09 | 
| WO2008079028A1 (en) | 2008-07-03 | 
| Publication | Publication Date | Title | 
|---|---|---|
| ATE553105T1 (de) | Azetidin-analoge ais nucleosidase- und phosphorylase-hemmer | |
| EA200901138A1 (ru) | Производные дианилинопиримидина как ингибиторы киназы wee1, фармацевтическая композиция и применение | |
| CL2008000670A1 (es) | Compuestos derivados de tiazolidindionas y oxazolidindionas sustituidas; composicion farmaceutica; proceso de preparacion de la composicion farmaceutica; y uso en el tratamiento de enfermedades tales como artritis reumatoide, epoc, cancer, entre otras. | |
| BRPI0915084B8 (pt) | composto, e, composição farmacêutica | |
| UA100840C2 (ru) | Композиция для лечения вирусного гепатита | |
| MX2009006704A (es) | Derivados de amina triciclicos como inhibidores de proteina de tirosina cinasa. | |
| TW200716646A (en) | (S)-N-methylnaltrexone | |
| PH12014500053A1 (en) | Proteasome inhibitors | |
| NO20092637L (no) | Fremgangsmater for behandling | |
| NO20083501L (no) | Azaindoler som er anvendelige som inhibitorer for Janus-kinaser | |
| NO20074823L (no) | Rasagilin-formuleringer med forbedret innholdsensartethet | |
| EA200901133A1 (ru) | Производные дианилинопиримидина как ингибиторы киназы wee1, фармацевтическая композиция и применение | |
| CL2007003774A1 (es) | Compuestos derivados de quinazolina sustituidos, inhibidores de quinasa; composicion farmaceutica; y uso en el tratamiento de enfermedades tales como cancer, aterosclerosis y artritis. | |
| MX2009009591A (es) | Aminopirimidinas utiles como inhibidores de proteinas cinasas. | |
| CL2007000806A1 (es) | Compuestos derivados de heteropentaciclos sustituidos; proceso de preparacion; compuestos intermediarios; composicion farmaceutica; y uso en el tratamiento del cancer. | |
| TW200738659A (en) | Novel compounds | |
| NO20090157L (no) | Tienpyrimidiner anvendelige som modulatorer av ionekanaler | |
| NO20073182L (no) | Indazol-karboksamidforbindelser | |
| TW200730518A (en) | Crystalline forms of docetaxel and processes for their preparation | |
| TW200724537A (en) | Pyrimidine derivatives for treatment of hyperproliferative disorders | |
| NO20070487L (no) | 3-aminocyklopentankarboksamider som modulatorer av kjemokinreseptorer. | |
| NO341679B1 (no) | Substituerte pyridylamidforbindelser, fremstilling av slike og farmasøytiske sammensetninger inneholdende slike, samt anvendelse som modulatorer av histamin H3-reseptoren | |
| TW200606162A (en) | Pyrazolopyridine derivatives | |
| DE602007010764D1 (en) | Benzamidglucokinaseaktivatoren | |
| TW200745122A (en) | New compounds I |